| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/08/2015 | US20150010561 Semaphorin 3C (Sema3C) Inhibitor Therapeutics, Methods, and Uses |
| 01/08/2015 | US20150010559 Anti-tlr4 antibodies and methods of use thereof |
| 01/08/2015 | US20150010551 Compositions and Methods of Treating Tumors |
| 01/08/2015 | US20150010549 Methods of Treating Amyotrophic Lateral Sclerosis |
| 01/08/2015 | US20150010541 Macrocyclic Compounds Useful as Inhibitors of Histone Deacetylases |
| 01/08/2015 | US20150010540 Combination therapy of an afucosylated cd20 antibody with a cd22 antibody-drug conjugate |
| 01/08/2015 | US20150010531 Compounds and methods for the treatment of vascular disease |
| 01/08/2015 | US20150010529 Thermally stable ph20 hyaluronidase variants and uses thereof |
| 01/08/2015 | US20150010524 Composition and method for treating nucleic acid-related eye disease |
| 01/08/2015 | US20150010512 Disease treatment via developing non-syngeneic graft transplantation |
| 01/08/2015 | US20150010509 Calcium folate (cafolate) and therapeutic methods based thereon |
| 01/08/2015 | US20150010508 Methods And Compositions Relating To Islet Cell Neogenesis |
| 01/08/2015 | US20150010505 Antiviral Compounds with a Dibenzooxaheterocycle Moiety |
| 01/08/2015 | US20150010504 Antiviral Compounds with a Heterotricycle Moiety |
| 01/08/2015 | US20150010503 Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer |
| 01/08/2015 | US20150010502 Compositions and Methods for Suppressing Gene Expression of p53 and Clusterin |
| 01/08/2015 | US20150010499 Insulin-mimetics as therapeutic adjuncts for bone regeneration |
| 01/08/2015 | US20150010496 Inkt cell modulators and methods of using the same |
| 01/08/2015 | US20150010495 Method for the production of an immunostimulating mucin (muc1) |
| 01/08/2015 | US20150010473 Diagnosis and treatment of tumors |
| 01/08/2015 | US20150010469 Bisphenol ether compounds with novel bridging groups and methods for their use |
| 01/08/2015 | DE102013011397A1 Acethylcholin-Esterasehemmer als Mittel zur Reduktion von Folgen erhöhten Stresses bzw. ihrer Prävention - bei iatrogenen Cushing-Syndrom und anderer, ua durch die HPA-Achse vermittelten unerwünschten Wirkungen bei hochdosierter, lange dauernder Gluto Acetylcholine esterase as a means to reduce stress and its consequences increased prevention - in iatrogenic Cushing's syndrome and other, including mediated by the HPA axis adverse effects with high-dose, long lasting Gluto |
| 01/07/2015 | EP2821083A1 Combined use of amides of mono- and dicarboxylic acids and silymarin in the treatment of renal diseases |
| 01/07/2015 | EP2821072A1 Pharmacological stimulation to facilitate and restore standing and walking functions in spinal cord disorders |
| 01/07/2015 | EP2821071A1 Compounds for breast cancer treatment |
| 01/07/2015 | EP2820030A1 Interleukin-3 polypeptide conjugates their uses |
| 01/07/2015 | EP2819692A1 Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes |
| 01/07/2015 | EP2819690A2 Method of treating chronic obstructive pulmonary disease |
| 01/07/2015 | EP2819687A1 Compositions and methods for treatment of peripheral vascular disease |
| 01/07/2015 | EP2819681A1 Method for improving functional synaptic connectivity |
| 01/07/2015 | EP2819677A1 Combination of selective progesterone-receptor modulators and nonsteroidal anti-inflammatory drugs |
| 01/07/2015 | EP2819676A1 Combination therapy for treating androgen deficiency |
| 01/07/2015 | EP2819635A1 Combination product for treating excess weight and/or for improving the figure |
| 01/07/2015 | CN104271159A 利用tor激酶抑制剂联合治疗来治疗非小细胞肺癌的方法 Tor kinase inhibitors using the method of combination therapy for the treatment of non-small cell lung cancer |
| 01/07/2015 | CN104271158A 多种抗人csf-1r抗体的联合疗法及其用途 More anti-human csf-1r antibody combination therapy and its use |
| 01/07/2015 | CN104271131A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并[3,4,b]吲哚]-4-胺和抗抑郁药的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol pyrano [3,4, b] indole] -4-amine and pharmaceutical compositions of antidepressants |
| 01/07/2015 | CN104267188A 针对msk1基因的相关制剂在制备5-fu耐药性检测试剂及5-fu耐药逆转剂方面的应用 Related preparations for the manufacture of genes msk1 5-fu resistance detection reagent and 5-fu resistance reversal agents aspects |
| 01/07/2015 | CN104258416A 基于寡聚核苷酸共递送药物和基因的纳米载体及制备方法 Total drug delivery and gene-based oligonucleotide nanocarriers and preparation methods |
| 01/07/2015 | CN104258398A Drd1及其激动剂在制备治疗nlrp3炎症小体相关炎症性疾病药物中的用途 Drd1 and agonists for the manufacture of small-associated inflammation nlrp3 treatment of inflammatory diseases medicine |
| 01/07/2015 | CN104258397A Dickkopf-3在治疗动脉粥样硬化中的功能和应用 Dickkopf-3 functions and applications in the treatment of atherosclerosis in |
| 01/07/2015 | CN104258396A Ⅱ型抑瘤素m受体在治疗动脉粥样硬化中的功能和应用 Oncostatin m type Ⅱ receptor in the treatment of atherosclerosis in the features and applications |
| 01/07/2015 | CN104258395A 核苷酸合成酶cad在治疗动脉粥样硬化中的功能和应用 Nucleotide synthase cad in the treatment of atherosclerosis in the features and applications |
| 01/07/2015 | CN104258394A 纳米银联合自噬抑制剂杀伤肿瘤 Nano-silver joint autophagy inhibitors kill cancer |
| 01/07/2015 | CN104258393A 碱性物质在去除体臭和/或脚臭方面的应用 Alkaline substance used in the removal of body odor and / or odor aspects |
| 01/07/2015 | CN104258392A Gαs蛋白或下游激动剂FSK在用于制备控制血管完整性和通透性药物中的应用 Gαs protein agonist or downstream FSK Application for the preparation of vascular integrity and control of drug permeability |
| 01/07/2015 | CN104258390A 针对人血管生成素-2的高亲和力人抗体 Angiopoietin-2 high-affinity human antibody against human |
| 01/07/2015 | CN104257646A 用于治疗高钙血症的亮氨酸来源和ω-3不饱和脂肪酸来源的组合 Leucine sources and for the treatment of hypercalcemia ω-3 unsaturated fatty acid-derived compositions |
| 01/07/2015 | CN104257610A 用于制备可吸入干粉所用的载体颗粒的方法 Methods for preparing inhalable dry powder carrier particles used for |
| 01/07/2015 | CN103083643B 增加肽、肽模拟物和其他胃肠道转运蛋白底物吸收的方法 Increase peptides, peptidomimetics, and other gastrointestinal transport protein substrates Absorption Method |
| 01/07/2015 | CN102247597B 一种糖皮质激素与支气管扩张剂的吸入剂 Glucocorticoids and bronchodilator inhaler |
| 01/06/2015 | US8927760 Colchicine derivatives or pharmaceutically acceptable salts thereof, method for preparing said derivatives, and pharmaceutical composition comprising said derivatives |
| 01/06/2015 | US8927726 N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions containing them and uses thereof |
| 01/06/2015 | US8927724 Isoxazole beta-lactamase inhibitors |
| 01/06/2015 | US8927716 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
| 01/06/2015 | US8927711 JAK kinase modulating compounds and methods of use thereof |
| 01/06/2015 | US8927658 Fluorescent hybrid of dendrimer and graphene oxide |
| 01/06/2015 | US8927600 Compound for use in the treatment of peripheral neuropathies |
| 01/06/2015 | US8927592 Antitumoral use of cabazitaxel |
| 01/06/2015 | US8927587 Chemical compounds |
| 01/06/2015 | US8927586 Thromboxane A2 (TP) receptor antagonists |
| 01/06/2015 | US8927570 1-naphthyl-or 1-dihydroacenaphthenyl-pyrido[B]indoles and uses thereof in treating cancers |
| 01/06/2015 | US8927553 Deuterium-enriched alkyl sulfonamides and uses thereof |
| 01/06/2015 | US8927547 Pyrimidine derivatives |
| 01/06/2015 | US8927546 Therapeutic piperazines |
| 01/06/2015 | US8927543 Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| 01/06/2015 | US8927540 Pyridazinone derivatives |
| 01/06/2015 | US8927532 Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases |
| 01/06/2015 | US8927531 Indanyloxydihydrobenzofuranylacetic acids |
| 01/06/2015 | US8927530 Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent |
| 01/06/2015 | US8927528 Composition for treating hearing loss |
| 01/06/2015 | US8927526 Fused aromatic PTP-1B inhibitors |
| 01/06/2015 | US8927505 Nutritive compositions and methods of using same |
| 01/06/2015 | US8927504 Combined use of dipeptidyl peptidase 4 inhibitor and sweetener |
| 01/06/2015 | US8927498 Compositions and methods useful in enhancement of memory |
| 01/06/2015 | US8927205 Recombinant polypeptides of the members of the TNF ligand family and use thereof |
| 01/06/2015 | US8927030 Use of nitrite salts for the treatment of cardiovascular conditions |
| 01/06/2015 | US8927021 Granulating process and thus prepared granulate |
| 01/06/2015 | US8927006 Methods and compositions for rapid treatment of otitis externa |
| 01/06/2015 | US8926990 Treatment and diagnosis of inflammatory disorders and HIV |
| 01/06/2015 | US8926973 Reducing the immunogenicity of fusion proteins |
| 01/06/2015 | US8926957 Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells |
| 01/06/2015 | US8926949 Composition for oral health treatment and related methods of use |
| 01/06/2015 | US8926595 Devices, formulations, and methods for delivery of multiple beneficial agents |
| 01/06/2015 | US8925493 Hoof bath system |
| 01/06/2015 | CA2637760C Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
| 01/06/2015 | CA2574907C Physiologically-active composition based on collagen |
| 01/01/2015 | US20150005391 Method of reducing scarring |
| 01/01/2015 | US20150005387 Composition containing agmatine, and uses thereof in preparing drugs or neutraceutical substances |
| 01/01/2015 | US20150005386 Methods of Reducing Risk of Cardiovascular Disease |
| 01/01/2015 | US20150005372 Compositions and methods of altering cholesterol levels |
| 01/01/2015 | US20150005356 Intranasal Formulation of Epinephrine for the Treatment of Anaphylaxis |
| 01/01/2015 | US20150005344 Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3-Dihydroxypropyl-6-Fluoro-2-(1-Hydroxy-2-Methylpropan-2-yl)-1H-lndol-5-yl)-Cyclopropanecarboxamide |
| 01/01/2015 | US20150005342 Hepatitis C Virus Inhibitors |
| 01/01/2015 | US20150005336 Opioid agonist/opioid antagonist/acetaminophen combinations |
| 01/01/2015 | US20150005328 Oximes For Treatment Of Peripheral And Central Nervous System Exposure to Acetyl Cholinesterase Inhibitors |
| 01/01/2015 | US20150005300 Pyridazinone compounds and methods for the treatment of cystic fibrosis |
| 01/01/2015 | US20150005295 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b |
| 01/01/2015 | US20150005284 Furo[3,2-b]- and thieno[3,2-b]pyridin derivatives |
| 01/01/2015 | US20150005278 Sulfoximine substituted quinazolines for pharmaceutical compositions |
| 01/01/2015 | US20150005272 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |